|
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
|
1R01CA231325-01
|
$572,540
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
5R01CA216265-02
|
$602,394
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-04
|
$119,807
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
|
5R01CA201250-03
|
$695,342
|
LARSON, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$314,516
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$154,883
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A pan-cancer role for MutL loss in inducing treatment resistance
|
1K22CA229613-01
|
$147,169
|
HARICHARAN, SVASTI
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A Patient-Centered Approach to Integration of Life Expectancy into Treatment Decision Making for Patients with Genitourinary Malignancy
|
1K08CA230155-01
|
$183,258
|
DASKIVICH, TIMOTHY
|
CEDARS-SINAI MEDICAL CENTER
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$477,453
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$477,453
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Academic-Industry Partnership for the Translation of a Novel Optical Imaging Approach to guide Endocrine Cancer Surgery
|
1R01CA212147-01A1
|
$563,912
|
MAHADEVAN-JANSEN, ANITA
|
VANDERBILT UNIVERSITY
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$813,241
|
Hofmann, Jonathan
|
DCEG (NCI)
|
|
ALK Rearrangements in Aggressive Thyroid Cancer
|
5R01CA181150-05
|
$313,721
|
NIKIFOROV, YURI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 10712
|
$40,865
|
Jones, Rena
|
DCEG (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
ATBC Study
|
ZIA CP010195 03031
|
$738,165
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Bayesian methods for complex, high-dimensional functional data in cancer research
|
5R01CA178744-04
|
$366,000
|
MORRIS, JEFFREY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCG therapy of bladder cancer: the role of BCG uptake by bladder cancer cells
|
5K08CA184038-05
|
$127,505
|
REDELMAN-SIDI, GIL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Bladder Cancer GWAS
|
ZIA CP010187 10461
|
$130,145
|
Rothman, Nat
|
DCEG (NCI)
|
|
Bladder cancer in the Northeastern U.S.
|
ZIA CP010125 02212
|
$157,102
|
Silverman, Debra
|
DCEG (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$331,774
|
Apolo, Andrea
|
CCR (NCI)
|
|
Bladder Fiducial Markers and Diffusion-MRI to Optimize Bladder Chemo-Radiotherapy
|
5R01CA201709-03
|
$724,638
|
GARCIA, MAURICE
|
CEDARS-SINAI MEDICAL CENTER
|
|
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
|
5R01CA181183-05
|
$361,050
|
NUCERA, CARMELO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Breast and other cancers following x-rays for scoliosis
|
ZIA CP010222 04150
|
$22,134
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)
|
5P20CA217231-02
|
$247,999
|
IRAZOLA, VILMA
|
INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-05
|
$562,579
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 04180
|
$145,295
|
Linet, Martha
|
DCEG (NCI)
|
|
Cancer Cell Mechanical Profiling Analysis
|
5R21CA208196-02
|
$203,580
|
RAO, JIANYU
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-47
|
$3,572,644
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S5
|
$10,405,362
|
PISTERS, PETER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S6
|
$123,760
|
PISTERS, PETER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA013696-44S1
|
$120,000
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S2
|
$60,000
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S4
|
$191,726
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|